Skip to main content
Clinical Trials/NCT07639853
NCT07639853Enrolling By InvitationNot Applicable

Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils

Medtronic Endovascular1 site in 1 country30 target enrollmentStarted: July 24, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Rate of peri-procedural adverse events

Study Overview

Brief Summary

The purpose of the Case-Specific Health Care Professional (HCP) Clinical Survey for Concerto Versa™ Detachable Coils, also known as the Concerto Versa HCP Clinical Assessment, is to collect early clinical data from HCPs to assess clinical safety and performance of the Concerto Versa™ Detachable Coils, when used in accordance with approved device labeling per the Instructions for Use (IFU). Data collected will generate clinical evidence to quantitatively assess clinical safety and device performance for the purpose of obtaining European Union Medical Device Regulation (EU MDR) approval.

Detailed Description

The Concerto Versa™ Health Care Professional (HCP) Clinical Assessment is a multicenter, prospective per patient HCP recollection survey. Participating HCPs will document their individual use case experience following routine utilization of Concerto Versa™ in accordance with the approved device labeling. Individual use cases will be entered within 72 hours of device usage to identify periprocedural safety incidents and evaluate device performance. At least 30 use cases will be collected and aggregated from participating HCPs. This data collection is a for a single point in time, with no patient follow-up. Individual HCP responses for each case will be aggregated by a third party vendor.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
22 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient treated with Concerto Versa™ Detachable Coil is age ≥ 22 years at the time of procedure.
  • Use of Concerto Versa™ Detachable Coil in accordance with the device labeling.
  • Reporting of case within 72 hours of index procedure.

Exclusion Criteria

  • Not provided

Arms & Interventions

Adult patients treated with Concerto Versa™ Detachable Coil

The Concerto Versa™ Detachable Coil is indicated for arterial and venous embolization in adult patients requiring embolization in the peripheral vasculature.

Intervention: Concerto Versa™ Detachable Coils (Device)

Outcomes

Primary Outcomes

Rate of peri-procedural adverse events

Time Frame: During the Index Procedure

The rate of peri-procedural adverse events related to device and/or procedure.

Rate of Technical Success

Time Frame: During the Index Procedure

Technical success is defined as successful delivery and detachment of the coil, and removal of the delivery-pusher.

Secondary Outcomes

  • Rate of Peri-procedural success(During the Index Procedure)

Investigators

Sponsor
Medtronic Endovascular
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials